HomepageIMRN ā¢ NASDAQ
add
Immuron ADR
Vorige slotkoers
$Ā 2,11
Dag-range
$Ā 2,13 - $Ā 2,37
Jaar-range
$Ā 1,48 - $Ā 5,96
Beurswaarde
20,58Ā mln. AUD
Gem. volume
7,13K
Marktnieuws
Financiƫle informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(AUD) | dec 2023info | Wijziging j-o-j |
---|---|---|
Opbrengst | 1,18Ā mln. | 303,60% |
Bedrijfskosten | 1,72Ā mln. | 49,58% |
Netto inkomsten | -1,04Ā mln. | -4,79% |
Netto winstmarge | -88,01 | 74,04% |
Winst per aandeel | ā | ā |
EBITDA | -925,42K | 0,81% |
Effectief belastingtarief | ā | ā |
Balans
Totale activa
Totale passiva
(AUD) | dec 2023info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 16,42Ā mln. | -14,23% |
Totale activa | 19,88Ā mln. | -13,93% |
Totale passiva | 2,36Ā mln. | 28,30% |
Totaal aandelenvermogen | 17,53Ā mln. | ā |
Uitstaande aandelen | 227,80Ā mln. | ā |
Koers-boekwaardeverhouding | 26,31 | ā |
Rendement op activa | -11,66% | ā |
Rendement op kapitaal | -13,10% | ā |
Kasstroom
Nettomutatie in liquide middelen
(AUD) | dec 2023info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | -1,04Ā mln. | -4,79% |
Operationele kasstroom | -1,00Ā mln. | -102,00% |
Kasstroom uit beleggingen | 76,75K | 105,90% |
Kasstroom uit financiering | -11,58K | -7,80% |
Nettomutatie in liquide middelen | -973,15K | 46,46% |
Vrije kasstroom | -580,79K | 1,36% |
Over
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Opgericht
1994
Hoofdvestiging
Website
Werknemers
6